This is massive news! I dont have access to the full article, but here is a quick summary
"Japanese drug major Astellas Pharma (TYO: 4503) today announced that Japan’s Ministry of Health, Labor and Welfare (MHLW) has approved Vyloy (zolbetuximab), an anti-claudin 18.2 (CLDN18.2) monoclonal antibody for patients with CLDN18.2 positive, unresectable, advanced or recurrent gastric cancer. Astellas noted that this makes Vyloy is the first and only CLDN18.2-targeted therapy approved by any regulatory agency in the world.
Why is this such big news?
https://www.thepharmaletter.com/article/astellas-gets-first-approval-for-vyloy-in-japan?mc_cid=b0fef19e05
https://www.pharmaceutical-technology.com/news/astellas-secures-approval-for-gastric-cancer-antibody-in-japan/?cf-view
- Forums
- ASX - By Stock
- ALA
- Astellas gets first approval for Vyloy, in Japan
ALA
arovella therapeutics limited
Add to My Watchlist
6.00%
!
9.4¢

Astellas gets first approval for Vyloy, in Japan
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
9.4¢ |
Change
-0.006(6.00%) |
Mkt cap ! $112.1M |
Open | High | Low | Value | Volume |
9.9¢ | 9.9¢ | 9.1¢ | $154.7K | 1.613M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 100000 | 9.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
9.4¢ | 21674 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 24999 | 0.092 |
3 | 231078 | 0.091 |
4 | 153156 | 0.090 |
1 | 57000 | 0.089 |
2 | 212685 | 0.087 |
Price($) | Vol. | No. |
---|---|---|
0.090 | 25000 | 1 |
0.097 | 70409 | 2 |
0.098 | 102030 | 1 |
0.099 | 84524 | 2 |
0.100 | 99990 | 1 |
Last trade - 16.10pm 12/08/2025 (20 minute delay) ? |
Featured News
ALA (ASX) Chart |